-
Nk cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models
Gruijs, M., Ganzevles, S. H., Stigter-Van Walsum, M., van der Mast, R., van Ostaijen-Ten Dam, M. M., Tuk, C. W., Schilham, M. W., Leemans, C. R., Brakenhoff, R. H., van Egmond, M., van de Ven, R. & Bakema, J. E., 1 Oct 2021, In: International journal of molecular sciences. 22, 20, 11057.Research output: Contribution to journal › Article › Academic › peer-review
-
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
Heemskerk, N., Gruijs, M., Robin Temming, A., Heineke, M. H., Gout, D. Y., Hellingman, T., Tuk, C. W., Winter, P. J., Lissenberg-Thunnissen, S., Bentlage, A. E. H., de Donatis, M., Bögels, M., Rösner, T., Valerius, T., Bakema, J. E., Vidarsson, G. & van Egmond, M., 15 Mar 2021, In: Journal of clinical investigation. 131, 6, e134680.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers
Uvyn, A., de Coen, R., Gruijs, M., Tuk, C. W., de Vrieze, J., van Egmond, M. & de Geest, B. G., 9 Sept 2019, In: Angewandte Chemie (International ed. in English). 58, 37, p. 12988-12993Research output: Contribution to journal › Article › Academic › peer-review
- All publications
